Medmix AG (CHIX:MEDXZ) Preferred Stock: CHF0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:MEDXZ Medmix AG CHIX:MEDXZ
70 GF Score
Price CHF9.15
GF Value CHF9.06
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Medmix AG Preferred Stock?

Medmix AG CHIX:MEDXZ -0.22% 70 Preferred Stock is CHF0.0 Mil as of Jun. 2026. GuruFocus rates CHIX:MEDXZ with a GF Score™ of 70/100 and a GF Value™ of CHF9.06 (Fairly Valued). The stock has 6 warning signs investors should review.

Preferred stock is a special equity security that has properties of both equity and debt. Medmix AG's preferred stock for the quarter that ended in Jun. 2026 was CHF0.0 Mil.

The market value of preferred stock needs to be added to the market value of common stocks in the calculation of Enterprise Value. Medmix AG's Enterprise Value for the quarter that ended in Jun. 2026 was CHF536.2 Mil.

In the calculation of book value, the par value of preferred stocks needs to subtracted from total equity. Medmix AG's Book Value per Share for the quarter that ended in Jun. 2026 was CHF10.19.

Dividends paid to preferred stocks need to be subtracted from net income in the calculation of Earnings per Share (Diluted). Medmix AG's Earnings per Share (Diluted) for the six months ended in Jun. 2026 was CHF0.01.


Medmix AG  (CHIX:MEDXz) Preferred Stock Explanation

When a company needs capital but does not wish to issue debt, they may sell preferred stocks to investors.

For instance, during the financial crisis of 2008, Goldman Sachs (GS) issued a combination of preferred stock and common stock options for $5 billion of capital to Warren Buffett’s Berkshire Hathaway (BRK.A)(BRK.B). In this deal, Berkshire Hathaway paid $5 billion for 10% cumulative perpetual preferred stock and warrants to buy 43.5 million shares of Goldman Sachs at $115 a share. Goldman Sachs bought back the preferred in 2010. Guess how much money Warren Buffett made in this deal in two years? Read How Much Did Warren Buffett’s Berkshire Hathaway (BRK.B) Make on Its Goldman Sachs (GS) Preferred Stock?

1. The market value of Preferred Stocks needs to be added to the market value of common stocks in the calculation of enterprise value.

Medmix AG's Enterprise Value for the quarter that ended in Jun. 2026 is calculated as

2. In the calculation of Book Value, the par value of Preferred Stocks needs to subtracted from total equity.

Medmix AG's Book Value per Share for the quarter that ended in Jun. 2026 is calculated as

3. Dividends paid to Preferred Stocks need to be subtracted from net income in the calculation of earnings per share.

Medmix AG's Earnings per Share (Diluted) (EPS) for the six months ended in Jun. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medmix AG Preferred Stock Related Terms


Medmix AG Preferred Stock Historical Data

* Premium members only.

The historical data trend for Medmix AG's Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medmix AG Preferred Stock Chart

Medmix AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Preferred Stock
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Medmix AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:MEDXZ
70GF Score
Medmix AG CHIX:MEDXZ
Preferred Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medmix AG Preferred Stock Calculation

Preferred Stock is a special equity security that has properties of both equity and debt. It is generally considered a hybrid instrument. Preferred stock is senior to common stock, but is subordinate to bonds in terms of claim or rights to their share of the assets of the company.

Preferred stock has priority over common stock in the payment of dividends and any payments received when a company liquidates.

Preferred stock comes in many forms. It can be:


Convertible or Non-Convertible
Cumulative or Non-Cumulative
Voting or Non-Voting
Callable or Non-Callable
Maturity Date or No Maturity Date

A preferred stock without a maturity date is called a perpetual preferred stock. These are relatively rare. A good example of perpetual preferred stock is the many series of Public Storage (PSA) preferred shares that trade on the New York Stock Exchange.

Before investing in preferred stock, it is important to know which of the above groups the stock belongs to. Is it convertible or non-convertible? Are dividends cumulative or non-cumulative?

It is also critical that an investor knows what bonds the company has in front of the preferred stock. Bondholders get paid first. So the decision to buy a preferred stock can be similar to the decision to buy a bond. But, remember, the preferred stock of a company with bonds is junior to those bonds.

Unless a preferred stock is convertible, the upside in a preferred stock investment is more limited than in a common stock investment. If a company doubles its earnings, it is usually under no more obligation to double the dividends paid to preferred shareholders than it is to double the interest paid to its bankers and bondholders.So preferred stock is very different from common stock.

Frequently Asked Questions Learn more about Preferred Stock →
What does a Preferred Stock of CHF0.0 Mil mean?
Medmix AG (CHIX:MEDXZ) has a Preferred Stock of CHF0.0 Mil as of Jun. 2026. Preferred Stock represents the par value of a company's preferred shares. View historical data on Medmix AG and its competitors.
Is Medmix AG's Preferred Stock too high?
Medmix AG's current Preferred Stock is CHF0.0 Mil. Overall, Medmix AG has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's Preferred Stock compare to GEV and ETN?
Medmix AG's Preferred Stock of CHF0.0 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Stock for an Industrial Products company?
A good Preferred Stock depends on the Industrial Products industry context. However, Preferred Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Stock mean?
A high Preferred Stock can signal that a stock is expensive relative to its fundamentals. Preferred Stock represents the par value of a company's preferred shares. View historical data on Medmix AG and its competitors. Medmix AG's current Preferred Stock is CHF0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Based on GuruFocus' analysis, Medmix AG (CHIX:MEDXZ) is currently considered Fairly Valued. The stock's GF Value™ is CHF9.06, compared to a current price of CHF9.15 — trading 1% above its estimated fair value. The current Preferred Stock is CHF0.0 Mil. Medmix AG's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Stock calculated?
Preferred Stock is calculated from a company's financial statements. For Medmix AG (CHIX:MEDXZ), the current Preferred Stock is CHF0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medmix AG (CHIX:MEDXZ) Overvalued in 2026?

Based on GuruFocus' analysis, Medmix AG stock appears to be overvalued. The current stock price of CHF9.15 is trading 1% above its estimated GF Value™ of CHF9.06. GuruFocus considers Medmix AG to be Fairly Valued.

Key valuation signals for CHIX:MEDXZ:

  • Preferred Stock: CHF0.0 Mil
  • GF Value™: CHF9.06 vs. price of CHF9.15 (1% above fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the CHIX:MEDXZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medmix AG Business Description

Other Exchanges MEDX:Switzerland
Address Neuhofstrasse 20, Baar, CHE, 6340
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
70GF Score

Get the complete analysis for CHIX:MEDXZ

Preferred Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF9.15
Price
CHF9.06
GF Value